Early versus delayed bronchial artery embolization for non-massive hemoptysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Sung-Joon | - |
dc.contributor.author | Lee, Sangjoon | - |
dc.contributor.author | Lee, Hyoung Nam | - |
dc.contributor.author | Cho, Youngjong | - |
dc.date.accessioned | 2022-08-02T02:40:14Z | - |
dc.date.available | 2022-08-02T02:40:14Z | - |
dc.date.issued | 2023-01 | - |
dc.identifier.issn | 0938-7994 | - |
dc.identifier.issn | 1432-1084 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/61251 | - |
dc.description.abstract | Objectives The aims of this study were to compare clinical outcomes of early versus delayed bronchial artery embolization (BAE) for non-massive hemoptysis and to investigate predictors of recurrent hemoptysis. Methods From March 2018 to February 2021, 138 consecutive patients (age, 65.5 ± 12.4 years; male, 67.4%) with non-massive hemoptysis underwent BAE. The enrolled patients were divided into an early embolization (EE) group (within the first 24 h, n = 79) and a delayed embolization (DE) group (n = 59). Results The time to embolization ranged between 0 and 15 days and was shorter in the EE group (0.47 ± 0.5 days) than in the DE group (4.02 ± 2.8 days, p < 0.001). The in-hospital clinical outcomes were not different between the two groups, except for hospital stay and post-embolization hospital stay. The recurrence-free survival in the EE group was significantly better than that in the DE group (p = 0.018). The time to embolization (hazard ratio (HR), 1.21; 95% confidence interval (CI), 1.04–1.42; p = 0.015) and aspergilloma (HR, 6.89; 95% CI, 2.08–22.86; p = 0.002) were predictive factors for recurrent hemoptysis. Conclusions BAE is an effective and safe treatment modality for non-massive hemoptysis. An early interventional strategy should be considered in patients presenting with non-massive hemoptysis to reduce the length of hospital stay and early recurrence. A delayed time to embolization and the presence of aspergilloma were independent risk factors for recurrent hemoptysis. Key Points • Bronchial artery embolization afforded good clinical improvement for treating non-massive hemoptysis without significant complications. • An early interventional strategy should be considered in patients presenting with non-massive hemoptysis to reduce the length of hospital stay and early recurrence. • A delayed time to embolization and the presence of aspergilloma were independent risk factors for recurrent hemoptysis. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Springer Verlag | - |
dc.title | Early versus delayed bronchial artery embolization for non-massive hemoptysis | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1007/s00330-022-08993-z | - |
dc.identifier.scopusid | 2-s2.0-85134513031 | - |
dc.identifier.wosid | 000826810100001 | - |
dc.identifier.bibliographicCitation | European Radiology, v.33, no.1, pp 116 - 124 | - |
dc.citation.title | European Radiology | - |
dc.citation.volume | 33 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 116 | - |
dc.citation.endPage | 124 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | LIFE-THREATENING HEMOPTYSIS | - |
dc.subject.keywordAuthor | Hemoptysis | - |
dc.subject.keywordAuthor | Bronchial arteries | - |
dc.subject.keywordAuthor | Therapeutic embolization | - |
dc.subject.keywordAuthor | Retrospective studies | - |
dc.subject.keywordAuthor | Survival rate | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.